1. Use of PET for monitoring cancer therapy and for predicting outcome;Weber;J Nucl Med,2005
2. Radiolabelling DOTA-peptides with 68Ga;Breeman;Eur J Nucl Med Mol Imaging,2005
3. 68Ga-labeled oligonucleotides for in vivo imaging with PET;Roivainen;J Nucl Med,2004
4. A gallium-labeled DOTA-alpha-melanocyte-stimulating hormone analog for PET imaging of melanoma metastases;Froidevaux;J Nucl Med,2004
5. Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data;Hofmann;Eur J Nucl Med,2001